Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

DBV Technologies S.A. buy melinda

Start price
€45.70
21.10.17 / 50%
Target price
€120.00
23.04.18
Performance (%)
-15.01%
End price
€38.84
23.04.18
Summary
This prediction ended on 23.04.18 with a price of €38.84. The prediction for DBV Technologies S.A. disappointed with a performance of -15.01%. melinda has a follow-up prediction for DBV Technologies S.A. where he still thinks DBV Technologies S.A. is a Buy. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
DBV Technologies S.A. -2.181% -2.181% -58.711% -87.496%
iShares Core DAX® 2.112% -0.367% 13.466% 16.854%
iShares Nasdaq 100 -2.197% -3.794% 38.426% 42.934%
iShares Nikkei 225® -1.555% -7.320% 18.451% 2.941%
iShares S&P 500 -0.472% -2.078% 27.488% 41.955%

According to melinda what are the pros and cons of DBV Technologies S.A. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread DBV Technologies S.A. diskutieren
Prediction Buy
Perf. (%) -15.01%
Target price 120.000
Change
Ends at 23.04.18



2018.02.14 | 7.58

PARIS (Agefi-Dow Jones) - Das Biotechnologie - Unternehmen DBV Technologies ( >> DBV Technologies ) Mittwoch bekannt gegeben , dass die Food and Drug Administration (FDA), die Autorität der US - Gesundheits, dass die Daten die Wirksamkeit bestätigt hatte und Sicherheit derzeit zur Verfügung stehende sein Flaggschiff ausreichend Viaskin Peanut eine Reihe von Anwendungspaket auf dem Markt zu bilden.

Viaskin Peanut Patch ist für die Behandlung von Erdnuss-Allergie in Kinder von 4 bis 11 Jahren.





Hoch reiten: DBV Technologies



DBV Technologies ist spezialisiert auf die Entwicklung von Diagnose und Behandlung von Nahrungsmittelallergie - Lösungen (insbesondere Erdnüssen und Kuhmilch) von einem Patch (Viaskin®) für die Verabreichung von Wirkstoffen in den ersten Schichten der Haut


In the thread DBV Technologies S.A. diskutieren
Prediction Buy
Perf. (%) -15.01%
Target price 120.000
Change
Ends at 23.04.18

(Laufzeit überschritten)

Current prediction by melinda for DBV Technologies S.A.

buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€1.57
09.12.23
€1.90
09.12.24
-20.00%
22.04.24

Could be worthwhile Investment >10% per year

Stopped prediction by melinda for DBV Technologies S.A.

buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€2.10
01.11.23
€2.50
01.11.24
-25.24%
09.12.23

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€2.81
24.12.22
-
24.12.23
-25.37%
01.11.23

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€5.24
27.11.21
€8.00
27.11.22
-47.90%
28.11.22

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.53
03.11.20
€10.50
04.11.21
51.47%
05.11.21

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€24.48
09.01.20
-
19.03.20
-74.65%
19.03.20

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€45.70
21.10.17
€120.00
23.04.18
-15.01%
23.04.18

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€61.85
01.06.17
€120.00
20.10.17
32.98%
20.10.17

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€63.28
19.04.16
€70.00
19.10.16
3.18%
19.10.16

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€37.46
22.10.14
€39.00
24.12.14
15.67%
24.12.14

Could be worthwhile Investment >10% per year